About us

Genomtec is a technology company operating in the field of clinical diagnostics. It was established in 2016 in Wrocław, with a vision of international expansion based on a unique mobile genetic diagnostics platform utilizing a patented contactless heating and detection system. The company, founded by a group of scientists with experience and competences in the field of molecular biology, microstructures and photonics, has its headquarters and laboratories in Wrocław. Genomtec also has an office in the United Kingdom, where part of the international research and engineering team is located.

Genomtec S.A. is mainly involved in conducting research and development activities, as well as commercialization of its innovative molecular diagnostic products in the area of optical systems and isothermal nucleic acid amplification methods.

The company’s flagship project is Genomtec ID. Its creation and commercialization will allow the diagnostic process to be executed in point of care setting, such as: primary care clinics, pharmacies, doctor’s offices, hospital emergency departments (ERs) without the need for complicated and time-consuming laboratory workflow conducted by qualified personnel. The main benefits of Genomtec ID are: small size of the analyzer, low energy consumption, shortened diagnostic time, wide spectrum and high accuracy of the analysis, as well as affordable price. All these features will put Genomtec ID ahead of other genetic diagnostic devices currently available on the global market.

Genomtec ID

The company’s ambition is to create a new standard for clinical genetic diagnostics using the Genomtec ID platform. Thanks to the mobility, speed and efficiency of the device that can help detect viruses, bacteria and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood or other body fluids, it will be possible to implement appropriate treatment during one medical visit.

Our Technology

The COVID-19 pandemic has shown that rapidly determining the pathogenesis, or causes of the disease, at the level of basic cellular structures (RNA and DNA) is the new expected standard. Genetic diagnostics already offers the highest level of efficiency and precision in detecting pathogens. Upcoming epidemic challenges, such as, for example, subsequent epidemic cycles, rising treatment costs, aging population or rise in occurance of of neoplastic diseases have pushed the bar in the development of diagnostic technologies. Speed, efficiency and cost-effectiveness – these are the features that products available on the medical screening and diagnostic market should have in the near future. These expectations are met by new technological solutions, i.e. devices that allow conducting point-of-care testing (POCT).

Since its beginnings in 2016, the Genomtec team knew that rapid genetic diagnosis is the future of the market. In addition, the company chose to work with the new technology of Loop-Mediated Isothermal Nucleic Acid Amplification – LAMP..

It is an important part of the developed analyzer’s design based on the patented SNAAT®technology, consisting of photon energy contactless heating and temperature detection embedded in the analyzer system, which together with the microfluidic card and firmware creats the Genomtec ID mobile genetic diagnostics platform.

Our story

Significant events for Genomtec SA

June 2021

Charudutt Shah appointed by Supervisory Board to join Genomtec Management Board starting August 1st, 2021.

June 2021

Participation in person in Arab Health Show in Dubai, UAE.

May 2021

Launch of newly registered in EU, the world’s first genetic diagnostic test for the detection of SARS-CoV-2 directly from a saliva sample Genomtec® RT-LAMP Direct Kit.

May 2021

Genomtec successfully co-organizes science and educational conference: “New technologies in the laboratory of the COVID-19 pandemic” with 430 participants and 708 registered diagnosticians to promote RT-LAMP technology.

March 2021

Designating 17 March 2021 as the first day of listing Genomtec SA shares on the NewConnect stock exchange trading floor.

February 2021

Introduction of Genomtec shares to the alternative trading system on the NewConnect market pursuant to a resolution of the Warsaw Stock Exchange. As previously announced by the Company, the debut will take place in the first quarter of this year and is planned for March.

January 2021

Krzysztof Krawczyk, Head of the Polish branch of CVC Capital Partners – a global leader in the private equity industry – joins Genomtec’s Supervisory Board. He is joined by Krzysztof Dębowski, who has worked for many companies in the hi-tech sector, and currently serves as the managing partner at KnowledgeHub Starter – one of the leading venture capital funds in Poland.

December 2020

Genomtec took third place in the 2020 “Maker in China” competition, directly supported by the China-CEEC SME Research Institute Government Organisation, in which over 300 companies from Central and Eastern Europe and China compete.

November 2020

Genomtec took second place in the 4th edition of the international competition “China Shenzhen Innovation & Entrepreneurship” for its Genomtec ID product beating over 1,000 other projects. The company received a cash prize of almost PLN 400,000 (RMB 650,000).

November 2020

Genomtec produces first 5 prototypes of Genomtec ID. The complete prototype allows conducting required tests for the reaction card, to optimize thermal parameters and to reduce the time of individual stages during result processing. The team is also working on developing the service and user interface software, as well as an algorithm for repeatable and reliable handling of the final version of the reaction card with improved fluid flow rate. The work also involves optimization of the optical system for fluorescence detection, which was parameterized for reliable detection of spectral emission specific for the dye used. Further work will include verification of optical filters to obtain the best fluorescence signal-to-noise ratio.

November 2020

Genomtec introduces a new product to the market, a two gene test for SARS-CoV-2 detection using RT-LAMP technology, CE-IVD labelled for sales throughout the EU. In-house analyses confirmed the effectiveness of the test for detecting new SARS-CoV-2 variants, i.e. British, South African and Brazilian variants, with mutations that can affect the efficacy of the genetic tests that are currently available on the market.

November 2020

The company successfully placed all of its 730,000 shares on offer as part of its IPO, and obtained over PLN 8 million, which the company will allocate to the Genomtec ID platform, its preparation for marketing and mass production. The offer went to institutional and individual investors. The interest of investors significantly exceeds the number of shares that the Company could allot to them.

October 2020

Patent application filed with the Patent Office of the Republic of Poland for Chlamydia trachomatis diagnostic kit: “A set of primers, reagent composition and a method for detection of atypical bacteria”.

October 2020

Commencement of the historical, first public offering through which Genomtec plans to raise PLN 8 million for the further development of its flagship project, Genomtec ID.

September 2020

The company receives the Money.pl Economic Award for the best technology of 2020.

September 2020

Genomtec is granted a patent by the American Patent Office for the invention entitled “Method of detecting genetic material in a biological sample and a device for its implementation”.

September 2020

Appointment to the Board of Michał Wachowski as Chief Financial Officer. Before joining the team, Michał was the investment director of the VC fund. A graduate of the Warsaw School of Economics in the field of Finance and Banking.

September 2020

Appointment to the Board of Jarek Oleszczuk, former president of the board of the Polish branch of the global pharmaceutical company Astra Zeneca, and previously the general director of Abbott Laboratories Polska. As Chief Business Officer (CBO), Jarek is responsible for the further development and implementation of the company’s business strategy.

September 2020

Genomtec receives nearly PLN 7 million (EUR 1.6 million) of funding from the National Centre for Research and Development (NCBiR) for its flagship project – a mobile molecular diagnostics system – Genomtec ID, which will be able to detect, among others, COVID-19 within 15 minutes. Genomtec was among the eight finalists of the competition, which were awarded co-financing under the 2014-2020 Smart Growth Operational Program, measure 1.1 under sub-measure 1.1.1 “Fast Track”. The total value of the project “Development of mobile diagnostic equipment for COVID-19 detection” amounts to almost PLN 11 million net (approx. EUR 2.4 million), including PLN 7 million (EUR 1.6 million) in funding from the National Centre for Research and Development.

July 2020

Obtaining a certificate of free sale (number 434/2020) from URPLiMB (Office for Registration of Medicinal Products, Medical Devices and Biocidal Products), for the diagnostic kit Genomtec® SARS-CoV-2 RT-LAMP/N CE-IVD Laboratory Kit. The certificate of free sale is issued for a product labelled with CE (it is the manufacturer’s declaration that the product that has been placed on the market meets the essential requirements, as well as legal regulations, quality and safety standards regarding this product) and reported to the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in order to facilitate export. The document confirms that the product indicated therein, on the date of issuing the certificate, is or could have been marketed and used within the territory of the Republic of Poland.

July 2020

Conclusion of a non-exclusive commercial cooperation agreement with Synektik S.A. concerning the distribution of SARS-CoV-2 tests developed by the Company in Poland. After the end of the initial period, i.e. 30 November, 2020, the terms of the contract negotiated by that time will enter into force, specifying the rules for further cooperation. The Agreement allows for the expansion of sales channels in Poland for the Company’s product lines, laboratory tests, and introduces active marketing of GNT (SNAAT®) technology in all channels used by Synektik S.A.

June 2020

Obtaining patent protection on the territory of Poland for a patent application entitled “Method of detecting genetic material in a biological sample and a device for its implementation”.

June 2020

Signing a conditional agreement with the UK-based CDMO company for the production of the Genomtec ID analyzer.

May 2020

Obtaining the consent of the USPTO expert to receive a patent for the invention entitled “Method of detecting genetic material in a biological sample and a device for its implementation” in the USA, which is a significant step towards obtaining patent protection.

May 2020

Filing two patent applications in the area of molecular biology under the name “Diagnostic Primers, Kits and Methods for Viral Detection” with the British Patent Office.

March 2020

Filing an application with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products for an invention entitled “Mycoplasma pneumoniae bacteria detection primer sets, Mycoplasma pneumoaniae infection detection method, Mycoplasma pneumoniae detection primer kit application” regarding small bacteria causing respiratory infections.

September 2019

Patent application filed for a kit used in diagnosis of selected, most oncogenic human papillomavirus types: HPV 16 and HPV 18 (a virus responsible for cancer development, transmitted mainly during sexual intercourse or a direct contact with the skin of a virus carrier).

July 2019

Genomtec signs a letter of intent with Astra Zeneca Pharma Poland concerning possibilities of commercial applications of the Company’s technology for diagnostics and personalized treatment of patients with non-small-cell lung carcinoma (NSCLC). It is one of the two main types of lung cancer, responsible for approx. 80% of cases.

January 2018

Another patent application filed with the Patent Office of the Republic of Poland “Kit for contactless temperature control, method for generating electromagnetic radiation wavefronts and kit’s application for generating temperature field profiles” regarding the method of using electromagnetic waves for contactless heating, which has a broad range of industrial applications. Currently, the application is being processed at the EUIPO and local patent offices in China, Japan and USA.

October 2017

Filing the first patent application in the field of molecular biology called “Primer kit for the detection of Borrelia burgdorferi, a method for the detection and diagnosis of Borrelia burgdorferi using a primer kit and kit for the detection of Borrelia burgdorferi” for bacteria that cause Lyme disease.

December 2016

Filing a key patent application with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products under the name “Method of detecting genetic material in a biological sample and a device for its implementation”. Patent proceedings are pending at EUIPO and local patent offices in Canada, China, Japan and Brazil.



Miron Tokarski, PhDChief Executive Officer (CEO)

Miron is the co-founder of Genomtec S.A. and its CEO. He is also a laboratory diagnostician. He graduated from the Faculty of Pharmacy with a Division of Medical Analytics at the Medical University of Wrocław. He received the title of Doctor of Medical Sciences in the field of molecular biology in December 2021 at the Medical University of Wrocław.

Author of a number of scientific publications and the co-author of Genomtec patents. Ambitious and young, but already an experienced scientist. He has won a number of awards and honors for his master’s thesis. Head of a research project for the National Science Center.

At Genomtec, in addition to managing the company, Miron actively participates in R&D in the field of molecular biology in the area of infectious diseases.

Michał WachowskiMember of the Management Board, Chief Financial Officer (CFO)

Michał has over 14 years of experience in the area of corporate finance, investment management and business consulting. Before joining the team, he was an investment director in an actively investing Venture Capital fund. Previously, he was a member of the Management Board of a medium-sized production company in the energy sector and Vice President, Finance in a start-up in the chemical industry. He has advised on a number of transactions in the field of investments, mergers and acquisitions, as well as restructuring processes. Previously, he held operational positions at ARP, TFS, Deloitte, Polimex-Mostostal and Central Europe Trust. He holds a Master’s degree from the Warsaw School of Economics in the field of Finance and Banking and has completed postgraduate studies in Information Technology Transfer to Enterprises.

At Genomtec, he is responsible for the company’s finances.

Charudutt ShahMember of the Management Board, Chief Business Officer

Charudutt is a senior executive with many years of international experience, incl. in the area of ​​business development, marketing and sales management and strategic planning in the clinical genetic diagnosis sector. He will start work at Genomtec on August 1, 2021. He has several years of leadership experience in the area of ​​product commercialization, brand development and partnership with international entities. A major focus of his efforts are in developing go to market strategies, driving clinician awareness, market access and bringing innovative testing solutions to various healthcare ecosystems to improve patient care.

Charudutt is a graduate of the University of Toronto and holds both a Bachelors of Applied Science and Engineering degree as well as a Masters of Biotechnology and Management degree. He also holds a certificate of Alliance Management from the Canadian Healthcare Licensing Association.

Lee HuntleyChief Technology Officer (CTO)

Lee brings over forty years of knowledge and experience in both product design and manufacture. He has spent nearly twenty years of his career in the medical instrumentation sector developing and taking products through to manufacture. The vast majority of his career has been spent in senior management/director engineering positions in a number of industries; medical, security, instrument parts manufacture, etc. Having managed his own successful design/manufacturing company within the instrumentation sector, he has also been providing business consultancy to the boards of technology/manufacturing companies.

At Genomtec Lee is responsible for the development and management of the engineering team.

Henryk Roguszczak, MScCo-founder, Chief Designer

Coordinator of R&D activities in the areas of the analyzer and diagnostic reaction cards. An expert at the Wroclaw University of Science and Technology at the Faculty of Microsystem Electronics and Photonics, a versatile, talented electronics engineer and a designer of advanced electronic devices. He co-created such devices as the portable X-ray source “Photon Needle” for medical applications for the Institute for Nuclear Studies in Świerk, a 300 W plasma generator for technological processes in the SECON device at the Institute of Electron Technology in Warsaw or IV Measurement Systems (Photoemission Tech, Inc. Camarillo US). An author of patents and over 80 domestic and foreign scientific publications. He was awarded the title of the second lieutenant of the Polish Armed Forces in the Central Training Center of Technical Specialists of the Air Force.

At Genomtec, he is responsible for coordination and implementation of technical solutions for the analyzer and diagnostic reaction cards.

Małgorzata Małodobra-Mazur, PhDCo-founder & Director of Research and Development (CRO)

Małgorzata is a graduate of the Medical University of Wrocław and a laboratory diagnostician. She received the title of doctor of medical sciences in December 2010. She has over 10 years of experience in the field of molecular biology. She is a specialist and expert in the field of INNAT (Isothermal Nucleic Acid Amplification Technology) molecular technologies. She has completed numerous workshops and research internships, including at the Joslin Diabetes Center, Harvard Medical School in Boston. In 2011-2013, she was employed as an assistant professor at the Laboratory of Cell Signals and Metabolic Disorders at the Institute of Experimental and Cell Biology at the Polish Academy of Sciences in Warsaw. Since 2010 she has been working as an scientific researcher at the Department of Molecular Techniques of the Medical University in Wrocław, and since 2015 as an assistant professor. Author of scientific publications and co-author of Genomtec technologies and patents.

At Genomtec, she is responsible for managing the molecular biology team and implementing new solutions in the field of genetics and diagnostic processes for innovative products.

Matylda Czosnykowska, PhDSenior Research Associate

Matylda is a graduate of the Medical University of Wrocław and a laboratory diagnostician with experience in the field of molecular biology. Author of scientific publications, she has conducted many research projects and coordinated clinical trials. In recent years, she has carried out her research work at the Department and Clinic of Neonatology, dealing with the nutritional aspect and biological activity of breast milk, while coordinating the Regional Bank of Breast Milk at the University Clinical Hospital in Wrocław. Expert in research on DNA and RNA of pathogens.

At Genomtec, she supports research and development in the field of molecular biology, managing the laboratory in Wrocław.

Mark Watson, CEng IMechESenior Engineer

A graduate of mechanical engineering from Brunel University London. A chartered member of the Institution of Mechanical Engineers, with over 30 years of continuous design and development experience with a mechanical and electromechanical bias, primarily within the instrumentation, medical device and process equipment industries, but also with early career experience in the high volume automotive ancillary equipment industry. Familiar with working in and often leading multidisciplinary teams to produce new products from concept through to full production. Readily able to work both at strategic (director/manager) and detailed (practitioner engineer) levels, generating ideas to meet customers’ needs and turning these ideas into commercial reality. Instrumental in introducing engineering standards and quality systems into the work environment and managing the impact associated with growth and change.

Arkadiusz Dąbrowski, PhDSenior Hardware Engineer

PhD in technical sciences, electronics, specialist in microelectronics, electronic and photonic materials engineering, sensors and transducers. A graduate of the Faculty of Microsystem Electronics and Photonics of the Wrocław University of Technology. Author of numerous scientific publications and patents. Contractor in research projects financed from public funds and industry.

At Genomtec he is responsible for the design of electronic circuits and tests of materials used to build the Genomtec ID device.

Kacper LipiecQuality Manager

Kacper studied at Wroclaw University of Technology, Biomedical Engineering at the Faculty of Fundamental Technological Research and Management and Production Engineering at the Faculty of Mechanical Engineering. He gained professional experience in quality management in the automotive industry and in an international corporation from the medical industry – a manufacturing company dealing with the production of disposable medical devices.

In Genomtec he is responsible for Quality Management System. One of his objectives is to have the QMS certified according to ISO 13485 and the Medical Device Single Audit Program, which will enable the registration of the company’s products in certain foreign markets in accordance with the existing regulatory requirements.

Tomasz Matusiak, PhDProduct Development Manager

Tomasz is a graduate of the Faculty of Electronics, Microsystems, and Photonics at Wroclaw University of Science and Technology. He specializes in microelectronics, sensors, and fluidic microsystems, with expertise in microfabrication techniques. Tomasz is also an author of scientific publications, focusing his research on the development of miniature sensors.

At Genomtec, he is responsible for product engineering, conducting V&V tests, and leading research and development efforts for Genomtec ID.

Prof. Tadeusz DoboszMolecular Biology Consultant

At Genomtec, he coordinates all R&D activities and oversees the work of the technological and biological-molecular team.

Professor Dobosz is a co-creator of the Genomtec technology, an outstanding Polish scientist with almost 50 years of scientific experience, and a widely recognized specialist in the field of clinical genetics. His scientific activity began at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław. Since 2004 he has been the head of the Molecular Techniques Unit at the Department of Forensic Medicine of the Wroclaw Medical University. He’s the author of 56 printed works occupying a spot on the ISI Master Journal List and over 470 scientific publications. The creator of many improvement and patenting proposals. Winner of 14 different prizes, including the Gold Cross of Merit, awarded for his achievements in the introduction of DNA testing technology to Polish forensic genetics, and the Knight’s Cross of the Order of Polonia Restituta. He was a part of two international teams of experts under the Society for Forensic Haemogenetics.

He has served multiple times as a technical auditor for the Polish Center for Accreditation.

DMSc Kamila KorzekwaMicrobiology Expert

She received the title of doctor of medical science at the Faculty of Medicine of the Wrocław Medical University. Currently, she is an adjunct professor at the Department of Microbiology at the Institute of Genetics and Microbiology of the University of Wrocław. Vice-president of the Wrocław Branch of the Polish Society of Microbiologists.

Kathrin Szczepańska, MScQuality Specialist

Kathrin graduated from the University of Wroclaw with a degree in biotechnology. She gained professional experience in the quality field with ISO 13485 and ISO 17025 while working as a Junior Research Quality Specialist at Pure Biologics, a biotech company, and at OIKOS Lab, a chemical analysis company.

At Genomtec, she is responsible for implementation and maintenance of the Quality Management System (QMS). Her primary objectives include coordinating general document control processes, and ensuring the training system is complying. He is also involved in expanding the scope of ISO 13485 certification and implementing the Medical Device Single Audit Program.

Aneta Cierzniak, PhDResearch Associate

Aneta graduated from the Medical University of Wrocław in the field of Laboratory Medicine. She is a laboratory diagnostician. Aneta received her doctorate degree in Medical Sciences in the field of Molecular Biology in September 2022. She is co-author of Genomtec patent applications for isothermal amplification method for the detection of genetic variant.

At Genomtec, Aneta is involved in research and development projects in the field of molecular biology.

Karolina Pląskowska, MSc.Junior Research Associate

Karolina is a graduate with distinction from the Faculty of Chemistry at the University of Wrocław. She is currently pursuing her PhD studies at Department of Molecular Microbiology at the University of Wroclaw where she is working with many model microorganisms and predatory bacterium and studying how they kill pathogenic bacteria. She is also a co-author of several scientific publications.

At Genomtec, she is part of molecular biology team and supports research and development activities in the laboratory.

Michał Ochnik, MSc EngJunior Research Associate

Michał is a graduate from the Wrocław University of Science and Technology with a degree in Molecular biotechnology and biocatalysis. He is currently a PhD student at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences where his research is focused on periodontitis and its influence on innate immunity conditions in Alzheimer’s disease patients. He has over 5 years of experience in antiviral research. 

At Genomtec he supports research activities in the molecular biology team.

Michał Grzebyk, MSc EngSenior Systems Engineer

Michal is a senior technical leader with adeptness in programming, managing engineering teams, coordinating R&D programs and delivering innovative solutions. He brings 22 years of experience in a journey that is enriched with extensive involvement in tech-pioneering enterprises, navigating through complex projects with a disciplined yet adaptive approach to scope, budget planning, and tech supervision. He has worked in dynamic evolving businesses by orchestrating agile teams and endorsing the consistent application of best practices. He is eager to embrace the AI-integrated future, marrying diverse technical and managerial expertise to foster innovative solutions in a fast-evolving market.

Michal is responsible for the management of Genomtec’s engineering teams in Wroclaw, PL.

Andrzej Chałupniak, PhDMicrofluidic Expert

Andrzej holds a degree from the Faculty of Biotechnology at the University of Wrocław and carried out his Ph.D. at the Catalan Institute of Nanoscience and Nanotechnology in Barcelona, Spain. His doctoral research focused on advancements in electrochemical and optical Lab-on-a-chip devices.

Subsequently, Andrzej embarked on a professional career at QIAGEN, where he honed his expertise in DNA/RNA extraction, PCR, dPCR technology, and various molecular biology techniques. This journey led him to Abbott Molecular, where he assumed a role in conducting customer training and implementation of automated CE-IVD systems for PCR technology.

As part of the Genomtec team, Andrzej responsible for the meticulous testing of microfluidic lab on a chip and contributes to other engineering activities related to development of Genomtec ID technology.

Amanda Solaniuk, MSc EngHardware Systems Engineer

Amanda graduated from Wroclaw University of Science and Technology as a Biomedical Engineering and Micro-mechatronics specialist. She brings professional experience from the space technology and biomedical engineering industry.

At Genomtec, she is responsible for the Systems Engineering process.

Krzysztof Adamczyk, MSc EngSoftware Engineer

Krzysztof graduated from the Faculty of Fundamental Problems of Technology at the Wrocław University of Science and Technology, where he completed a Bachelor’s degree in Biomedical Engineering and a Master’s degree in Big Data Analytics. Krzysztof started as a student at Genomtec working in software development, algorithm design and R&D processes concerning heat transfer.

Currently he is a full-time employee and a valuable member of the Software team.

Michał Sarnowski, MSc EngSenior Software Engineer

Michal is an Embedded systems programmer with 7 years of experience, developing software for many pioneering projects. Recently associated with the development of FW architectures targeting mass-market applications. He is also an author of a patent for an ultrasonic welding machine.

Michal oversees the software development activities at Genomtec including algorithms, user interface and firmware.

Piotr Olszewski, MSc EngElectronics Engineer

Piotr graduated with honors from Wrocław University of Science and Technology in 2018. He is a mechatronics engineer specializing in RF electronics and electromagnetic compatibility. His prior experience involves designing and deploying of radio modules for low Earth orbit satellites.

In his current role at Genomtec he helps with design of devices for EMC testing.

Karol Hirsz, MSc EngSoftware Engineer

Karol holds a master’s degree from Gdansk University of Technology. He is a software engineer specializing in embedded software with almost 10 years of experience. Focused on embedded systems and Linux drivers, but also quite familiar with OOP and desktop application development. He possesses extensive knowledge in the domain of communication protocols, security systems, and hardware accelerators.

At Genomtec, he is responsible for software development for Genomtec ID device.

Ewelina Wołoszyn, MScOffice Administration and HR Specialist

Ewelina is a graduate from the University of Economics in Wrocław. She is a member of the Association of Accountants in Poland and a Certified independent accountant.

At Genomtec she supports employees and management in everyday challenges and changes, as well she`s always ready for solving any upcoming issues. As a HR Specialist she is dedicated to supporting our employees and driving organizational success through effective human resources strategies.  She is always focused on promoting employee engagement and development.

Wojciech Antosz, PhDSenior Research Associate

Wojciech is a graduate of the Jagiellonian University in Cracow. He received his PhD degree in 2019 from the University of Regensburg.  He is an author of scientific publications and patent in the fields of gene expression and bioengineering. For several years, he worked as a Head of Cell Culture Laboratory and Project Manager in Polish Centre for Technology Development in Wroclaw. His main area of focus are molecular biology, nucleic acids and bioengineering.

At Genomtec, he supports research and development in the fields of diagnostic processes. He is engaged in the optimization of isothermal amplification technologies for pathogen identification and cancer diagnostics.

Iwona Chromik, PhDSenior Research Associate

Iwona completed her doctoral studies in molecular biology at Medical University in Wrocław and obtained a PhD in 2011. She also holds a Masters degree from the Gdańsk Medical University. In 2016, she achieved certification as a clinical embryologist conferred by the Polish Society of Reproductive Medicine and Embryology (PTMRiE). She has over 15 years of professional experience in the field of molecular biology, as well as medical diagnostics, embryology, and forensic genetics. Since 2021, she has been participating in a specialization in Forensic Genetics Laboratory conducted at the Medical University of Lublin. From 2019 to 2023, she worked as the deputy head of the forensic genetics laboratory where she was responsible for laboratory management as well as accreditation of tests in accordance with the PN-EN ISO/IEC 17025:2017 and DAB-10 standards.

At Genomtec, Iwona supports research and development activities in the field of molecular biology and assists in coordinating laboratory operations.

Jakub Koperski, MScGrants Administrator

Jakub graduated from the Lodz University Faculty of Law and Administration. His studies focused mainly on issues related to the theory and philosophy of law, as well as European and international law.

At Genomtec, he is responsible for compliance and is a key member of the team responsible for maintaining project documentation, managing financing and communication with intermediary institutions, as well as coordinating requests for proposals with suppliers.

Scientific Advisory Board

Scientific Advisory Board

Prof. Krishnendu ChakrabartyMember of Scientific Advisory Board

Krishnendu Chakrabarty received the B. Tech. degree from the Indian Institute of Technology, Kharagpur, in 1990, and the M.S.E. and Ph.D. degrees from the University of Michigan, Ann Arbor, in 1992 and 1995, respectively. He is now the John Cocke Distinguished Professor and Department Chair of Electrical and Computer Engineering (ECE), and Professor of Computer Science, at Duke University. He has held Visiting Professor positions and Chair Professorships at University of Tokyo (Japan), University of Bremen (Germany), Tsinghua University (China), National Tsinghua University (Taiwan) and National Cheng-Kung University (Taiwan). He has been awarded with multiple awards and scholarships all over the globe.

Prof. Chakrabarty’s current research projects include: design-for-testability of integrated circuits and systems (especially 3D integration and system-on-chip); microfluidic biochips; hardware security; machine learning for fault diagnosis, failure prediction, healthcare, and biochemical analysis; neuromorphic computing systems. His research has been supported by the National Science Foundation, DARPA, Office of Naval Research, National Institutes of Health, Army Research Office, Semiconductor Research Corporation, and directly by companies such as Intel, Cisco, and HP. He has published 26 books (with one book translated into Chinese) and over 800 peer-reviewed papers on these topics. He holds 18 US patents (with) two patents pending) and his research on microfluidic biochips has been licensed by Advanced Liquid Logic, Illumina, GenMark, and Baebies Inc. His test technology solutions have been adopted by Intel, TSMC, Samsung, Mentor Graphics (now part of Siemens), and Qualcomm. He has supervised 36 PhD dissertations.

Prof. Chakrabarty is a Fellow of ACM, a Fellow of IEEE, a Fellow of AAAS, a Golden Core Member of the IEEE Computer Society, and a Senior Member of the National Academy of Inventors. He was a Distinguished Visitor of the IEEE Computer Society (2005-2007, 2010-2012), a Distinguished Lecturer of the IEEE Circuits and Systems Society (2006-2007, 2012-2013), and an ACM Distinguished Speaker (2008-2016). Prof. Chakrabarty served as the Editor-in-Chief of IEEE Design & Test of Computers during 2010-2012, ACM Journal on Emerging Technologies in Computing Systems during 2010-2015, and IEEE Transactions on VLSI Systems during 2015-2018. He is an Associate Editor of IEEE Transactions on Biomedical Circuits and Systems. He has served in the past as an Associate Editor of IEEE Transactions on Computers, IEEE Transactions on Multiscale Computing Systems, IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems, ACM Transactions on Design Automation of Electronic Systems, IEEE Transactions on Circuits and Systems I, and IEEE Transactions on Circuits and Systems II. He has also served as General Co-Chair (2014, 2019) and Program Co-Chair (2005) of the IEEE Asian Test Symposium.



3rd place

Genomtec took third place in the 2020 “Maker in China” competition, directly supported by the China-CEEC SME Research Institute Government Organisation, in which over 300 companies from Central and Eastern Europe and China compete. Genomtec ID is attracting the attention of Chinese investors, and the company is reassured that its efforts will be backed by the Chinese government’s anticipated expansion in that market at the local and central level.


2nd place

Genomtec took second place in the 4th edition of the international competition “China Shenzhen Innovation & Entrepreneurship” and received an award of RMB 650,000 RMB, which is about PLN 400,000. Its innovative Genomtec ID platform beat out international competition with 1,046 projects entered. This win opens up new business and development opportunities on the Chinese market for the Company.


1st place

Genomtec wins the “Next Health Investment Pitch” competition organised for Polish companies who want to define economic reality through their innovations via Amgen and ImpactCEE. Amgen has been an international pioneer in biotechnology since 1980 and one of the world leaders in the production of biological medicines.


1st place

Genomtec won the “Start Up Med” competition organised by the 4th Health Challenges Congress, a forum for a multi-topic discussion on key issues for healthcare systems in Europe.



Genomtec was one of the five finalists of “InCredibles” – an acceleration program aimed at the most innovative and promising entrepreneurs organised by Kulczyk Investments.


2nd place

Genomtec won second place in the “Shark Tank” competition organised by New Frontiers in Interventional Cardiology, during an international educational and industry meeting for representatives of medicine and related fields in cardiology, surgery and cardiac/vascular imaging.



Genomtec received a distinction in the “Eagle of Innovation” competition organised by Rzeczpospolita in the category of product and service innovations. In this competition, Rzeczpospolita honours young companies – start-ups – that offer innovative and value-creating products or services.


1st place

Genomtec took 1st place as the best non-US start-up participating in HUBweek, an annual innovation festival held since 2014 by The Boston Globe, Harvard University, Massachussetts General Hospital, which brings together the most creative minds that influence art, science, and technology.



Genomtec received a distinction in the competition “Architects of Innovation” in the category of “emerging technologies”, which aims to distinguish companies and institutions that focus on innovative solutions, enter new markets, and are not afraid to be a precursor of new trends.



Genomtec was one of the finalists of the Biomed PFR Academy, an educational initiative for innovative pharmaceutical and medical companies.



Genomtec received a distinction in the competition “Architects of Innovation” in the category of “emerging technologies”, which aims to distinguish companies and institutions that focus on innovative solutions, enter new markets, and are not afraid to be a precursor of new trends.



Miron Tokarski, co-founder and CEO of Genomtec was included on the “Forbes: 30 under 30” list, composed of the most promising young entrepreneurs, innovators, investors, managers, economists and business activists in Poland.


1st place

Genomtec won the “CVC Young Innovator Awards” competition organised by MIT Enterprise Forum Poland in the acceleration program for start-ups from Central and Eastern Europe in collaboration with MIT and world leading investment funds, such as CVC Capital, dynamically supporting the company’s development.


1st place

Genomtec received the main “Innovation Initiator” award in the “Start-up” category from Newsweek Polska in a competition rewarding and promoting companies and institutions for whom innovation is the primary goal.


3rd place

Genomtec won a bronze medal in the “Pitch to London” annual competition for the best start-ups from Poland, during which they had the opportunity to present themselves to British experts and investors.


9th place

Miron Tokarski ranked 9th among the “Top 50 Creative People in Business”, a year-round program involving the exchange of knowledge, experience and business opportunities, rewarding managers for innovation and unconventional solutions in their business.



Miron Tokarski wins the 2nd edition of the “Young Talents” competition in the “Success in innovation” category organised by the Lower Silesian Capital Club. The “Young Talents” competition aims to promote and appreciate young scientists and students from Lower Silesia who have achieved significant success.


Join the Team!

At Genomtec, everything you do translates into a quick diagnosis that has an impact on people’s lives. We are a company with a flat organisation structure, where everyone can talk to each other, and the decision-making process is transparent and consulted with Team Members. We do not implement development levels, we abolish them in order to develop ourselves and our technology in the spirit of an interdisciplinary and international team, helping patients obtain a quick and accurate diagnosis.

Current career opportunities

We are seeking a individual to join our Quality Assurance/Quality Management System team as the intern. This position offers an excellent opportunity to gain valuable experience in quality management within our organization for a future career development in quality field within In-Vitro Diagnostics (due to the same ISO standard for the QMS, it’s quite similar Medical Devices branch, what ultimately offers broad possibilities for future career development on local & international markets).

We are looking for a person with positive approach, who’s point of view would be a “challenge” instead of a “problem“. The candidate will participate in supporting team, that is having overall responsibility for our quality management system and compliance with required regulatory standards for our industry.

The opportunity offers the possibility to grow the knowledge base in regard of quality management, actively participate in creation & improvement of QMS and also to document first on-the-job experience with Quality Assurance & Quality Management System daily work.

Location: ul. Bierutowska, Wrocław



  • Work closely with the quality management team to understand and contribute to the implementation of quality standards (ISO 13485) and EU 2017/746 (IVDR)
  • Assist in the development and maintenance of the Quality Management System (QMS).
  • Supporting all activities related to documentation for Product Registration purposes (EU 2017/746 (IVDR)).
  • Collaborate with cross-functional teams to ensure compliance with quality standards.
  • Participate in the documentation and communication of quality procedures.



  • Fluent English in speaking and writing due to documentation maintained in English and part of the team being native English speakers.
  • Certain level of knowledge/experience in using MS Office and cloud based electronic systems
  • Interest in quality assurance and quality management systems.
  • Eagerness to learn and contribute to the improvement of quality processes.
  • Availability for 100+ working hours per month.
  • Preferably “Close to graduation” student or recent graduate in a related field (e.g., engineering and management of manufacturing, quality management) who would like to earn first work-experience.


We Offer:

  • Paid internship
  • Opportunity to gain practical experience in quality management.
  • Exposure to various aspects of quality assurance within the organization.
  • Training and mentorship from experienced professionals.
  • Positive and collaborative work environment.


How to Apply:

Interested candidates are invited to send their CV to recruitment@genomtec.com. Please include “QA/QMS Internship“ in the subject of the email.

Participants for Apprenticeship for the research and development department, a person with versatile interests who can work with both the biotechnology and engineering teams.

Location: Wrocław


Are we looking for you?

  • You have strong motivation to learn new things
  • You are open-minded person
  • You like discuss and share ideas
  • You want to verify your knowledge from studies and apply in real life!

If each of the above points is correct – it means that you are probably who we are looking for!


Main tasks

  • learn about testing the mechanical and electronic subsystem
  • participation in sharing ideas
  • designing basic mechanical components and electronic circuits
  • preparation testing documentation


Person that we are looking for, should:

  • Be interested in the systems design & testing
  • Has communicative level of English
  • Has basic knowledge of electronic circuits
  • Have an wide overview through various subsystems
  • Be student of Mechatronic, Electronics, Mechanical Engineering, Biomechanical Engineering or similar


We offer:

  • Apprenticeship in our company with possibility of constant employment
  • participation in a worldwide unique implementation project, work on a revolutionary system for medical diagnostics POC (Point-of-Care)
  • attractive, challenging work in an interdisciplinary R&D team
  • large scope for independent responsibility and outstanding career development opportunities
  • friendly and sympathetic atmosphere in the team


If the above description is consistent with your profile and professional ambitions, we would like to meet you. Please, apply and send us your cv at: recruitment@genomtec.com stating Apprenticeship in the email subject.